Struma Ovarii: A Thyroxine-Producing Ovarian Tumor in Pregnancy

Struma ovarii is a rare dermoid tumor that consists of more than 50% thyroid tissue. The incidence of struma ovarii is reported to be 1% of all ovarian tumors and 2-5% of all ovarian teratomas. The authors present a case of struma ovarii diagnosed during the first trimester of pregnancy in a primigr...

Descripción completa

Detalles Bibliográficos
Autores principales: Botros, Karim, Noor Chelsea, Nadiha, Bermingham, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Obstetrics/Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547369/
https://www.ncbi.nlm.nih.gov/pubmed/34722068
http://dx.doi.org/10.7759/cureus.18292
_version_ 1784590366308040704
author Botros, Karim
Noor Chelsea, Nadiha
Bermingham, John
author_facet Botros, Karim
Noor Chelsea, Nadiha
Bermingham, John
author_sort Botros, Karim
collection PubMed
description Struma ovarii is a rare dermoid tumor that consists of more than 50% thyroid tissue. The incidence of struma ovarii is reported to be 1% of all ovarian tumors and 2-5% of all ovarian teratomas. The authors present a case of struma ovarii diagnosed during the first trimester of pregnancy in a primigravida patient and discuss the clinical presentation, diagnosis, and management options for such rare tumors, both in and outside of pregnancy. 
format Online
Article
Text
id pubmed-8547369
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-85473692021-10-29 Struma Ovarii: A Thyroxine-Producing Ovarian Tumor in Pregnancy Botros, Karim Noor Chelsea, Nadiha Bermingham, John Cureus Obstetrics/Gynecology Struma ovarii is a rare dermoid tumor that consists of more than 50% thyroid tissue. The incidence of struma ovarii is reported to be 1% of all ovarian tumors and 2-5% of all ovarian teratomas. The authors present a case of struma ovarii diagnosed during the first trimester of pregnancy in a primigravida patient and discuss the clinical presentation, diagnosis, and management options for such rare tumors, both in and outside of pregnancy.  Cureus 2021-09-26 /pmc/articles/PMC8547369/ /pubmed/34722068 http://dx.doi.org/10.7759/cureus.18292 Text en Copyright © 2021, Botros et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Obstetrics/Gynecology
Botros, Karim
Noor Chelsea, Nadiha
Bermingham, John
Struma Ovarii: A Thyroxine-Producing Ovarian Tumor in Pregnancy
title Struma Ovarii: A Thyroxine-Producing Ovarian Tumor in Pregnancy
title_full Struma Ovarii: A Thyroxine-Producing Ovarian Tumor in Pregnancy
title_fullStr Struma Ovarii: A Thyroxine-Producing Ovarian Tumor in Pregnancy
title_full_unstemmed Struma Ovarii: A Thyroxine-Producing Ovarian Tumor in Pregnancy
title_short Struma Ovarii: A Thyroxine-Producing Ovarian Tumor in Pregnancy
title_sort struma ovarii: a thyroxine-producing ovarian tumor in pregnancy
topic Obstetrics/Gynecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547369/
https://www.ncbi.nlm.nih.gov/pubmed/34722068
http://dx.doi.org/10.7759/cureus.18292
work_keys_str_mv AT botroskarim strumaovariiathyroxineproducingovariantumorinpregnancy
AT noorchelseanadiha strumaovariiathyroxineproducingovariantumorinpregnancy
AT berminghamjohn strumaovariiathyroxineproducingovariantumorinpregnancy

Ejemplares similares